title: CEA-negative glioblastoma and melanoma cells are sensitive to cytosine deaminase/5-fluorocytosine therapy directed by the carcinoembryonic antigen promoter.
authors.affiliation: Department og Immunochemistry, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
authors.forename: Anna
authors.initials: A
authors.lastname: Dabrowska
authors.forename: Jarosław
authors.initials: J
authors.lastname: Szary
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Kowalczuk
authors.forename: Stanisław
authors.initials: S
authors.lastname: Szala
authors.forename: Maciej
authors.initials: M
authors.lastname: Ugorski
mesh_terms: D001483:Base Sequence; D002272:Carcinoembryonic Antigen / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D043525:Cytosine Deaminase / Q000235:genetics* / Q000378:metabolism; D018076:DNA, Complementary / Q000235:genetics; D004273:DNA, Neoplasm / Q000235:genetics; D004926:Escherichia coli / Q000201:enzymology / Q000235:genetics; D005437:Flucytosine / Q000627:therapeutic use*; D015316:Genetic Therapy; D005909:Glioblastoma / Q000235:genetics / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D008545:Melanoma / Q000235:genetics / Q000276:immunology* / Q000628:therapy*; D011355:Prodrugs / Q000627:therapeutic use*; D011401:Promoter Regions, Genetic; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014162:Transfection
chemical_list: D002272:Carcinoembryonic Antigen; D018076:DNA, Complementary; D004273:DNA, Neoplasm; D011355:Prodrugs; D005437:Flucytosine; D043525:Cytosine Deaminase